QDEL Misses Q1 Revenue Estimates Amid Weak Flu Season and China Concerns
Apr 16, 2026, 2:11 PM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting
The significant revenue miss and negative cash flow outlook are serious concerns that could lead to continued investor skepticism and pressure on QDEL's stock price, similar to past reactions in weak earnings reports by similar companies.
AI summary
What happened, with direct paths to the underlying reporting
QuidelOrtho (QDEL) reported preliminary Q1 revenues significantly below expectations due to a weak flu season and issues in the Chinese market. The company anticipates negative free cash flow in the first half of 2026, raising concerns among investors about future performance.
QDEL's Q1 revenue is projected at $615-$620 million, missing expectations.
Weak respiratory season in the U.S. decreased flu-related visits by 30%.
Free cash flow expected to be negative in H1 2026, at $(65)-$(70) million.
Ongoing uncertainty in China exacerbates financial performance challenges.
Stock price fell 32.13%, trading at a new 52-week low.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event
- QuidelOrtho reported quarterly earnings of $0.44 per share, beating expectations. - Revenue for QuidelOrtho stood at $711 million, surpassing estimates by 1.96%. - The company's…